KalVista Pharmaceuticals, Inc. (KALV)

17.07 +0.16 (+0.95%) USD  |  NASDAQ  |  Dec 15, 12:35
More

KalVista Pharmaceuticals Average Diluted Shares Outstanding (Quarterly)

Average Diluted Shares Outstanding (Quarterly) Chart

View Average Diluted Shares Outstanding (Quarterly) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Quarterly) Benchmarks

View Average Diluted Shares Outstanding (Quarterly) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade
Xenetic Biosciences, Inc. Upgrade
BeyondSpring, Inc. Upgrade